USE OF CARNOSINE IN THE PREVENTION OF CARDIOMETABOLIC RISK FACTORS IN OVERWEIGHT AND OBESE INDIVIDUALS: STUDY PROTOCOL FOR A RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

Use of carnosine in the prevention of cardiometabolic risk factors in overweight and obese individuals: study protocol for a randomised, double-blind placebo-controlled trial

Introduction Carnosine, an over the counter food supplement, has been shown to improve glucose metabolism as well as cardiovascular risk factors in animal and human studies through its anti-inflammatory, antioxidative, antiglycating ackermans lace curtains and chelating properties.The aim of this study is to establish if carnosine supplementation i

read more